• Profile

Incidence, treatment, and outcomes of primary and recurrent Non-Wilms renal tumors in children: Report of 109 patients treated at a single institution

Journal of Pediatric Urology Jul 04, 2020

Qureshi SS, Bhagat M, Verma K, et al. - Researchers investigated the incidence of non-Wilms renal tumors as well as the associated diagnostic challenges, therapies and, outcomes at the largest tertiary cancer center in India. In the pediatric oncology unit of Tata Memorial Hospital, 569 patients with renal tumors were reported between 2006 and 2019; of these, 109 (19%) patients had primary (n = 97) or recurrent (n = 12) non-Wilms renal tumors. Clear cell sarcoma (CCSK) (39.4%), renal cell carcinoma (RCC) (19.3%), malignant rhabdoid tumor (MRTK) (12.8%), Ewing's sarcoma (rES) (15.6%), synovial sarcoma (2%), and undifferentiated sarcoma (2%) were the histological high-risk group. Surgery alone results in excellent outcomes in low-risk tumors while the high-risk tumors were associated with a variable outcome. The worst survival was observed in correlation with MRTK and recurrent non-Wilms tumor. In this study, CCSK and RCC had favorable outcomes and MRTK was associated with worst outcomes. Higher incidence of treatment failure and unsatisfactory outcomes were observed for renal ES. An extremely poor outcome was reported among those with recurrent non-Wilms tumors and more alternative or innovative approaches are required for their treatment.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free.
  • 55 lakhs+ doctors trust M3 globally

  • Nonloggedininfinity icon
    Unlimited access to original articles by experts
  • Nonloggedinlock icon
    Secure: we never sell your data
  • Signing up takes less than 2 mins
Try M3 India / Log In
M3 app logo
Choose easy access to M3 India from your mobile!

M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen